Transcriptomics

Dataset Information

0

CCND2 rearrangements are the most frequent genetic events in Cyclin D1-negative mantle cell lymphoma [Agilent]


ABSTRACT: Cyclin D1-negative mantle cell lymphomas (MCL) are not well characterized, in part due to the difficulties in their recognition. SOX11 has been recently identified as a reliable biomarker of MCL, also expressed in the cyclin D1-negative variant. We investigated 40 lymphomas with MCL morphology and immunophenotype, negative for cyclin D1 expression/t(11;14)(q13;q32) but SOX11-positive. These tumors presented clinically with generalized lymphadenopathy, advanced stage, and had a poor outcome (5-year overall survival 48%). Chromosomal rearrangements of the CCND2 locus were detected in 55% of the cases, with an IG gene as partner in 18/22 cases, in particular with light chains (10 IGK@, 5 IGL@). No mutations in the phosphorylation motifs of CCND1, CCND2 and CCND3 were detected. The global genomic profile and the high complexity of the 32 cyclin D1-negative SOX11-positive MCL analyzed by copy number arrays were similar to the conventional cyclin D1/SOX11-positive MCL. 17p deletions and high Ki67 expression conferred a significantly worse outcome to the patients. This comprehensive characterization of a large series of cyclin D1-negative MCL indicates that these tumors are clinically and biologically similar to the conventional cyclin D1-positive MCL and provides a basis for the proper identification and clinical management of these patients. Copy number analysis of Agilent 1*1M arrays was performed for 27 MCL, with sex-matched control DNAs and without duplicates or dye-swapt.

ORGANISM(S): Homo sapiens  

SUBMITTER: Sílvia Beà   Silvia Beà  Itziar Salaverria 

PROVIDER: E-GEOD-42917 | ArrayExpress | 2012-12-19

SECONDARY ACCESSION(S): GSE42917PRJNA183926

REPOSITORIES: GEO, ArrayExpress

altmetric image

Publications


Cyclin D1(-) mantle cell lymphomas (MCLs) are not well characterized, in part because of the difficulties in their recognition. SOX11 has been identified recently as a reliable biomarker of MCL that is also expressed in the cyclin D1(-) variant. We investigated 40 lymphomas with MCL morphology and immunophenotype that were negative for cyclin D1 expression/t(11;14)(q13;q32) but positive for SOX11. These tumors presented clinically with generalized lymphadenopathy, advanced stage, and poor outcom  ...[more]

Similar Datasets

2012-12-19 | E-GEOD-42935 | ArrayExpress
2011-07-01 | GSE25613 | GEO
2011-07-01 | E-GEOD-25613 | ArrayExpress
2014-11-04 | E-GEOD-52892 | ArrayExpress
| GSE52146 | GEO
| GSE52148 | GEO
2014-08-07 | E-GEOD-52148 | ArrayExpress
2013-04-04 | E-GEOD-34763 | ArrayExpress
2010-10-07 | E-GEOD-16024 | ArrayExpress
| PRJNA183923 | ENA